Incoming Boston Scientific (NYSE:BSX) CEO Michael Mahoney discusses his decision to leave Johnson & Johnson (NYSE:JNJ) in 2011 for the top job at the Natick, Mass.-based medical device company.

This clip is taken from a longer interview at the MassDevice Big 100 East in July, 2012.

Click here for more information on attending our next MassDevice Big 100 event in Newport Beach, Calif.